Brynne Jensen

Brynne Jensen currently serves as an MSAT Engineer at Denali Therapeutics since April 2024, following a tenure as Senior Associate Scientist/Engineer at The Janssen Pharmaceutical Companies of Johnson & Johnson, where expertise in viral vector late-stage process development was honed. Responsibilities included leading process modeling projects, creating training series for statistical software, and managing commercial lifecycle support across multiple sites. Prior experiences encompass roles at Eurofins PSS Insourcing Solutions specializing in CAR-T process development, as well as positions at GSK focusing on upstream manufacturing of monoclonal antibodies and Grōv Technologies involving analytical development for agricultural technology. A Bachelor’s degree in Chemical Engineering from Brigham Young University complements Brynne Jensen's extensive technical and leadership capabilities across various sectors in the life sciences industry.